Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan P Johnson

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
The Journal of Antimicrobial Chemotherapy|October 27, 2025
Two Decades of BSAC Resistance SurveillanceJames C Hurley, Alan P Johnson
BMJ (Clinical Research Ed.)|June 17, 2008
The emergence of Stenotrophomonas maltophiliaAlan P Johnson, Georgia J Duckworth
The Journal of Antimicrobial Chemotherapy|August 7, 2012
Fidaxomicin: a new option for the treatment of Clostridium difficile infectionAlan P Johnson, Mark H Wilcox
The Journal of Antimicrobial Chemotherapy|July 28, 2005
Surveillance and epidemiology of MRSA bacteraemia in the UKAlan P Johnson, Andrew Pearson, Georgia Duckworth
The Journal of Antimicrobial Chemotherapy|September 30, 2008
The European Antibiotic Awareness DayCliodna A M McNulty, Alan P Johnson
The Journal of Antimicrobial Chemotherapy|July 4, 2002
In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocciAlan P Johnson, Marina Warner, David M Livermore
International Journal of Antimicrobial Agents|August 3, 2007
Isolation and antimicrobial sensitivities of Kluyvera spp. from humans in England, Wales and Northern Ireland, 2005-2006Berit Muller-Pebody, Mark Lillie, Alan P Johnson
Antibiotics (Basel, Switzerland)|March 31, 2016
Antibiotic Stewardship Initiatives as Part of the UK 5-Year Antimicrobial Resistance StrategyAlan P Johnson, Diane Ashiru-Oredope, Elizabeth Beech
The Journal of Antimicrobial Chemotherapy|April 7, 2016
PrefaceVirve I Enne, Alan P Johnson, John D Perry
Journal of Medical Microbiology|June 10, 2017
How do the epidemiology of paediatric methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus bacteraemia differ?Julia Abernethy, Mike Sharland, Alan P Johnson, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
The Journal of Antimicrobial Chemotherapy|October 27, 2025
Two Decades of BSAC Resistance SurveillanceJames C Hurley, Alan P Johnson
BMJ (Clinical Research Ed.)|June 17, 2008
The emergence of Stenotrophomonas maltophiliaAlan P Johnson, Georgia J Duckworth
The Journal of Antimicrobial Chemotherapy|August 7, 2012
Fidaxomicin: a new option for the treatment of Clostridium difficile infectionAlan P Johnson, Mark H Wilcox
The Journal of Antimicrobial Chemotherapy|July 28, 2005
Surveillance and epidemiology of MRSA bacteraemia in the UKAlan P Johnson, Andrew Pearson, Georgia Duckworth
The Journal of Antimicrobial Chemotherapy|September 30, 2008
The European Antibiotic Awareness DayCliodna A M McNulty, Alan P Johnson
The Journal of Antimicrobial Chemotherapy|July 4, 2002
In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocciAlan P Johnson, Marina Warner, David M Livermore
International Journal of Antimicrobial Agents|August 3, 2007
Isolation and antimicrobial sensitivities of Kluyvera spp. from humans in England, Wales and Northern Ireland, 2005-2006Berit Muller-Pebody, Mark Lillie, Alan P Johnson
Antibiotics (Basel, Switzerland)|March 31, 2016
Antibiotic Stewardship Initiatives as Part of the UK 5-Year Antimicrobial Resistance StrategyAlan P Johnson, Diane Ashiru-Oredope, Elizabeth Beech
The Journal of Antimicrobial Chemotherapy|April 7, 2016
PrefaceVirve I Enne, Alan P Johnson, John D Perry
Journal of Medical Microbiology|June 10, 2017
How do the epidemiology of paediatric methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus bacteraemia differ?Julia Abernethy, Mike Sharland, Alan P Johnson, et al.
Pageof 10